Higher hepatic ANGPTL3 expression resulted in higher plasma ANGPTL3 levels, which were positively associated with clinical/histological markers of NAFLD/NASH. Here, ANGPTL3 is linked to metabolic dysfunction-associated steatotic liver disease.